Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies-Reference-Cited by-同舟云学术

Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies

Published:2016-03-01 Issue:3 Volume:101 Page:945-952
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Loomis A. Katrina¹,Kabadi Shaum¹,Preiss David²,Hyde Craig¹,Bonato Vinicius¹,St. Louis Matthew¹,Desai Jigar¹,Gill Jason M. R.²,Welsh Paul²,Waterworth Dawn³,Sattar Naveed²

Affiliation:

1. Pfizer Worldwide Research and Development (A.K.L., S.K., C.H., V.B., M.S.L., J.D.), Groton, Connecticut 06340-5159, and Pfizer Worldwide Research and Development, New York, New York 10017

2. British Heart Foundation Glasgow Cardiovascular Research Centre (D.P., J.M.R.G., P.W., N.S.), University of Glasgow, Glasgow G12 8TA, United Kingdom

3. Cardiovascular, Metabolic and Dermatology Genetics Unit (D.W.), GlaxoSmithKline, King of Prussia, Pennsylvania 19406

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/101/3/945/13619292/jcem0945.pdf

Reference25 articles.

1. Obesity-associated liver disease;Marchesini;J Clin Endocrinol Metab,2008

2. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging;Dyson;Frontline Gastroenterol,2014

3. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis;Williams;Lancet,2014

4. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012